{"title":"[COMORBIDITIES IN PATIENTS WITH ENDOMETRIAL HYPERPLASIA].","authors":"S A Fetesku","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The aim was to evaluate the prevalence of concomitant somatic pathology in patients with endometrial hyperplasia. It is shown that the incidence of endometrial hyperplastic processes of combination and somatic pathology is 50%. The main types of comorbid diseases are obesity, metabolic syndrome, gastrointestinal and cardiovascular disorders.</p>","PeriodicalId":18100,"journal":{"name":"Likars'ka sprava","volume":" ","pages":"157-9"},"PeriodicalIF":0.0000,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Likars'ka sprava","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The aim was to evaluate the prevalence of concomitant somatic pathology in patients with endometrial hyperplasia. It is shown that the incidence of endometrial hyperplastic processes of combination and somatic pathology is 50%. The main types of comorbid diseases are obesity, metabolic syndrome, gastrointestinal and cardiovascular disorders.